Literature DB >> 19183150

Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia.

M M Walker1, N J Talley, M Prabhakar, C J Pennaneac'h, P Aro, J Ronkainen, T Storskrubb, W S Harmsen, A R Zinsmeister, L Agreus.   

Abstract

BACKGROUND: Irritable bowel syndrome (IBS) and functional dyspepsia (FD) are common functional disorders without defined pathology. Mast cells and eosinophils interact with T lymphocytes and may alter enteric nerve and smooth muscle function. AIM: To examine mast cell, eosinophil and intraepithelial lymphocyte populations in duodenal biopsies of subjects with IBS and FD.
METHODS: A random sample of an adult Swedish population (n = 1001; mean age 54 years; 51% female) underwent upper endoscopy and biopsy; 51 cases with FD and 41 cases with IBS were compared with 48 randomly selected controls. Eosinophils were identified by light microscopy; mast cells by immunocytochemistry (CD117). Intraepithelial lymphocytes were counted per 100 enterocytes. Cell counts were quantified by counting the number per high power field (HPF) in 5HPFs in the bulb (D1) and second part of duodenum (D2), summed over 5HPFs at each site.
RESULTS: Cases and controls showed similar demographics. Compared to controls, IELs in IBS-constipation were significantly increased (P = 0.005). Mast cells were significantly increased in IBS in D2 (P < 0.001), while eosinophils were significantly increased in FD in D1 and D2 (P < 0.001).
CONCLUSION: Duodenal mast cell hyperplasia is linked to IBS and eosinophilia to FD, and duodenal biopsy may identify subsets of these disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19183150      PMCID: PMC4070654          DOI: 10.1111/j.1365-2036.2009.03937.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  43 in total

Review 1.  Differential secretion of cytokines.

Authors:  Redwan Moqbel; Jason J Coughlin
Journal:  Sci STKE       Date:  2006-06-06

Review 2.  The functional gastrointestinal disorders and the Rome III process.

Authors:  Douglas A Drossman
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

Review 3.  Irritable bowel syndrome.

Authors:  N J Talley
Journal:  Intern Med J       Date:  2006-11       Impact factor: 2.048

Review 4.  Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis.

Authors:  Ian Brown; Mari Mino-Kenudson; Vikram Deshpande; Gregory Y Lauwers
Journal:  Arch Pathol Lab Med       Date:  2006-07       Impact factor: 5.534

5.  5-hydroxytryptamine induces mast cell adhesion and migration.

Authors:  Nataliya M Kushnir-Sukhov; Alasdair M Gilfillan; John W Coleman; Jared M Brown; Sandra Bruening; Miklos Toth; Dean D Metcalfe
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

Review 6.  Allergy and intestinal dysmotility--evidence of genuine causal linkage?

Authors:  Simon Murch
Journal:  Curr Opin Gastroenterol       Date:  2006-11       Impact factor: 3.287

Review 7.  Functional gastroduodenal disorders.

Authors:  Jan Tack; Nicholas J Talley; Michael Camilleri; Gerald Holtmann; Pinjin Hu; Juan-R Malagelada; Vincenzo Stanghellini
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

Review 8.  Functional bowel disorders.

Authors:  George F Longstreth; W Grant Thompson; William D Chey; Lesley A Houghton; Fermin Mearin; Robin C Spiller
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

Review 9.  Review article: intestinal serotonin signalling in irritable bowel syndrome.

Authors:  G M Mawe; M D Coates; P L Moses
Journal:  Aliment Pharmacol Ther       Date:  2006-04-15       Impact factor: 8.171

10.  Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study.

Authors:  Pertti Aro; Tom Storskrubb; Jukka Ronkainen; Elisabeth Bolling-Sternevald; Lars Engstrand; Michael Vieth; Manfred Stolte; Nicholas J Talley; Lars Agréus
Journal:  Am J Epidemiol       Date:  2006-03-22       Impact factor: 4.897

View more
  72 in total

1.  Overlap syndrome of functional dyspepsia and irritable bowel syndrome - are both diseases mutually exclusive?

Authors:  Hidekazu Suzuki; Toshifumi Hibi
Journal:  J Neurogastroenterol Motil       Date:  2011-10-31       Impact factor: 4.924

2.  Mast cells and intestinal motility disorders (mastocytic enteritis/colitis).

Authors:  David F Schaeffer; Richard Kirsch; Robert H Riddell
Journal:  Dig Dis Sci       Date:  2012-05       Impact factor: 3.199

Review 3.  What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

Authors:  Antonella Scalera; Matteo Nicola Dario Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 4.  Eosinophils and mast cells as therapeutic targets in pediatric functional dyspepsia.

Authors:  Craig A Friesen; Jennifer V Schurman; Jennifer M Colombo; Susan M Abdel-Rahman
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-11-06

Review 5.  Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions.

Authors:  Lena Ohman; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01-26       Impact factor: 46.802

Review 6.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

7.  Evidence for neuronal and structural changes in submucous ganglia of patients with functional dyspepsia.

Authors:  Carla Cirillo; Talat Bessissow; An-Sofie Desmet; Hanne Vanheel; Jan Tack; Pieter Vanden Berghe
Journal:  Am J Gastroenterol       Date:  2015-06-16       Impact factor: 10.864

8.  Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia.

Authors:  Kok-Ann Gwee
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

9.  From cytokines to toll-like receptors and beyond - current knowledge and future research needs in irritable bowel syndrome.

Authors:  Oscar Rodríguez-Fandiño; Joselín Hernández-Ruiz; Max Schmulson
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

10.  Duodenal implications in the pathophysiology of functional dyspepsia.

Authors:  Kwang Jae Lee; Jan Tack
Journal:  J Neurogastroenterol Motil       Date:  2010-07-26       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.